About Afrinext
Afrinext is a Healthcare company based in India. Pharmaceutical manufacturing, export, and related healthcare services in India. The company has 1 employees. Its Indian entity Afrinext Overseas Private Limited reported revenue of ₹144 Cr. Afrinext offers products and services including Pharmaceutical Finished Form and Medical Devices. Its focus areas include Medical Devices, Production, Distribution and Pharmaceuticals.
Company details
Afrinext Overseas Pvt. Ltd. is headquartered in Vadodara, Gujarat, India, and has been operational since 2017. It is recognized as a STAR EXPORT HOUSE by the Indian government and specializes in manufacturing and exporting a diverse array of pharmaceutical products, including tablets, capsules, injections, surgical items, medical devices, herbal remedies, and cosmetics. Products are distributed to over 20 countries, with an emphasis on quality control and regulatory compliance being maintained through WHO-GMP certified facilities. Customer satisfaction is achieved through customized formulations and efficient distribution networks.
- Headquarters India
- Employees 1
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website afrinext.in
- Social LinkedIn Facebook
- Legal Name Afrinext Overseas Pvt. Ltd
- Date of Incorporation 13 Apr, 2017
- Jurisdiction Vadodara, Gujarat, India
- Annual Revenue₹144 Cr
FY 2025 · +65% YoY
- Net Profit₹2.83 Cr
FY 2025 · 2% margin
- EBITDA₹4.08 Cr
FY 2025 · 3% margin
- Employee Count1
Associated legal entities of Afrinext
Afrinext operates through Afrinext Overseas Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Afrinext Overseas Private Limited CIN U74999GJ2017PTC096837 | Active | 13 Apr 2017 | Vadodara, Gujarat | ₹144 Cr | 1 | 2 | View details |
Products & Services of Afrinext
Afrinext offers a comprehensive portfolio of products and services, including Pharmaceutical Finished Form and Medical Devices.
A wide range of medications is manufactured and exported by the company, covering items like tablets and capsules.
High-quality medical devices are produced and distributed globally by the company for various healthcare needs.
Board of directors of Afrinext Overseas Private Limited (Afrinext)
Afrinext Overseas Private Limited is the primary company behind Afrinext. The board of Afrinext Overseas Private Limited currently have 2 directors; the longest-serving is Hitesh Lalwani, appointed in 2017.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Hitesh Lalwani DIN 07786107 | Director | 13 Apr 2017 | 9 yrs 6 mo | Afrinext Overseas Private Limited |
| Nidhi Lalwani Hitesh DIN 07786118 | Director | 13 Apr 2017 | 9 yrs 6 mo | Afrinext Overseas Private Limited |
Financials of Afrinext
Figures of Afrinext Overseas Private Limited, the primary company behind Afrinext, for FY 2025. Revenue was ₹144 Cr (+65% year on year). Net profit was ₹2.83 Cr (2% margin). EBITDA was ₹4.08 Cr (3% margin). Revenue has grown at a compounded annual rate of +10% over three years and +34% over five years.
- ₹144 CrRevenue · FY 2025 · +65% YoY
- ₹2.83 CrNet profit · 2% margin
- ₹4.08 CrEBITDA · 3% margin
- ₹10 LakhPaid-up capital
- 1Employees (provident fund records)
- +10%Revenue CAGR, 3 years
- +34%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Afrinext Overseas Private Limited are on its company page.
Detailed financial statements for Afrinext
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Afrinext
Afrinext is headquartered in India.
Afrinext has 1 employees.
The primary company behind Afrinext, Afrinext Overseas Private Limited, reported revenue of ₹144 Cr for FY 2025, up 65% year on year.
Afrinext Overseas Pvt. Ltd. is headquartered in Vadodara, Gujarat, India, and has been operational since 2017. It is recognized as a STAR EXPORT HOUSE by the Indian government and specializes in manufacturing and exporting a diverse array of pharmaceutical products, including tablets, capsules, injections, surgical items, medical devices, herbal remedies, and cosmetics. Products are distributed to over 20 countries, with an emphasis on quality control and regulatory compliance being maintained through WHO-GMP certified facilities. Customer satisfaction is achieved through customized formulations and efficient distribution networks.
Afrinext offers Pharmaceutical Finished Form and Medical Devices.
Afrinext operates through Afrinext Overseas Private Limited.
The legal entities of Afrinext currently have 2 directors, including Hitesh Lalwani, Nidhi Lalwani Hitesh.